- Lobbying
- Lobbying by AMGEN, INC
Lobbying Relationship
Bills mentioned
S.1679: Affordable Health Choices Act
Sponsor: Tom Harkin (D-Iowa)
H.R.3590: Patient Protection and Affordable Care Act
Sponsor: Charles B. Rangel (D-N.Y.)
H.R.4872: Health Care and Education Reconciliation Act of 2010
Sponsor: John M. Spratt Jr. (D-S.C.)
S.1769: Options for Investors through United States Certified Coins Act of 2009
Sponsor: David Vitter (R-La.)
H.R.1548: Pathway for Biosimilars Act
Sponsor: Anna G. Eshoo (D-Calif.)
H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act
Sponsor: Henry A. Waxman (D-Calif.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Brent Heberlee | Legislative Director, Rep. James Bilbray Legislative Assistant, Senator Richard Bryan Legislative Director, Senator Richard Bryan |
Sherry Harper | Legislative Director, Congressman Ron Kind |
Roy Coffee | n/a |
Timothy W. Jenkins | n/a |
FREDERICK T. DOMBO | n/a |
B. Keith Heard | n/a |
DANIELLE FAGRE | n/a |
Patrick O'Donnell | n/a |
Timothy Jenkins | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate